Search research articles
Contact Us
Filters
Showing results (61-70 of 284) with videos related to
Page
of 29
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 12, 2001
Clinical outcome after front-line intensive sequential chemotherapy (ISC) in patients with aggressive non-Hodgkin's lymphoma and high-risk international prognostic index (IPI 3): final analysis of survival in two consecutive ISC trials
R Bouabdallah, A M Stoppa, D Coso, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 29, 1998
Role of induction chemotherapy and bone marrow transplantation in adult lymphoblastic lymphoma: a report on 62 patients from a single center
R Bouabdallah, L Xerri, V J Bardou, et al.
Bone Marrow Transplantation
|
June 1, 2000
The dismal outcome in patients with acute leukaemia who relapse after an autograft is improved if a second autograft or a matched allograft is performed. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)
O Ringdén, M Labopin, N C Gorin, et al.
Bone Marrow Transplantation
|
March 29, 2000
Potential allogeneic graft-versus-tumor effect in a patient with ovarian cancer
J O Bay, B Choufi, C Pomel, et al.
Leukemia & Lymphoma
|
November 8, 2001
Survey of early disapearance of BCR/ABL fusion transcript after allogeneic or autologous stem cell transplantation for chronic myelogenous leukemia
N Vey, G Balatzentko, M Lafage, et al.
Pathologie-Biologie
|
September 1, 1991
Histological evolution of peripheral T-cell lymphomas. Study of six cases
N Horschowski, D Sainty, G Sebahoun, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy
|
December 1, 1991
Cell surface expression of ICAM-1 (CD54) and LFA-3 (CD58), two adhesion molecules, is up-regulated on bone marrow leukemic blasts after in vivo administration of high-dose recombinant interleukin-2
D Olive, M Lopez, D Blaise, et al.
Bone Marrow Transplantation
|
March 7, 1998
High-dose chemotherapy and haematopoietic stem cell transplantation for inflammatory breast cancer: pathologic response and outcome
P Viens, F Penault-Llorca, J Jacquemier, et al.
British Journal of Haematology
|
January 1, 1993
In vivo administration of recombinant granulocyte colony stimulating factor corrects acquired neutrophil function deficiency association with chronic graft-versus-host disease
A M Stoppa, C Fossat, D Sainty, et al.
Bone Marrow Transplantation
|
April 13, 2021
Related versus unrelated allogeneic HPC graft cryopreservation: a single-center experience in the context of the global COVID-19 pandemic
B Mfarrej, C Lemarié, A Granata, et al.
Page
of 29
Search research articles
Search
Showing results (61-70 of 284) with videos related to
Sort By:
Page
of 29
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 12, 2001
Clinical outcome after front-line intensive sequential chemotherapy (ISC) in patients with aggressive non-Hodgkin's lymphoma and high-risk international prognostic index (IPI 3): final analysis of survival in two consecutive ISC trials
R Bouabdallah, A M Stoppa, D Coso, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 29, 1998
Role of induction chemotherapy and bone marrow transplantation in adult lymphoblastic lymphoma: a report on 62 patients from a single center
R Bouabdallah, L Xerri, V J Bardou, et al.
Bone Marrow Transplantation
|
June 1, 2000
The dismal outcome in patients with acute leukaemia who relapse after an autograft is improved if a second autograft or a matched allograft is performed. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)
O Ringdén, M Labopin, N C Gorin, et al.
Bone Marrow Transplantation
|
March 29, 2000
Potential allogeneic graft-versus-tumor effect in a patient with ovarian cancer
J O Bay, B Choufi, C Pomel, et al.
Leukemia & Lymphoma
|
November 8, 2001
Survey of early disapearance of BCR/ABL fusion transcript after allogeneic or autologous stem cell transplantation for chronic myelogenous leukemia
N Vey, G Balatzentko, M Lafage, et al.
Pathologie-Biologie
|
September 1, 1991
Histological evolution of peripheral T-cell lymphomas. Study of six cases
N Horschowski, D Sainty, G Sebahoun, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy
|
December 1, 1991
Cell surface expression of ICAM-1 (CD54) and LFA-3 (CD58), two adhesion molecules, is up-regulated on bone marrow leukemic blasts after in vivo administration of high-dose recombinant interleukin-2
D Olive, M Lopez, D Blaise, et al.
Bone Marrow Transplantation
|
March 7, 1998
High-dose chemotherapy and haematopoietic stem cell transplantation for inflammatory breast cancer: pathologic response and outcome
P Viens, F Penault-Llorca, J Jacquemier, et al.
British Journal of Haematology
|
January 1, 1993
In vivo administration of recombinant granulocyte colony stimulating factor corrects acquired neutrophil function deficiency association with chronic graft-versus-host disease
A M Stoppa, C Fossat, D Sainty, et al.
Bone Marrow Transplantation
|
April 13, 2021
Related versus unrelated allogeneic HPC graft cryopreservation: a single-center experience in the context of the global COVID-19 pandemic
B Mfarrej, C Lemarié, A Granata, et al.
Page
of 29